Skip to main content
. 2000 Apr 24;2000(2):CD002139. doi: 10.1002/14651858.CD002139

a01 MRC LU02.

Methods RCT ‐ 1965‐68
Participants 643 patients
Interventions surgery vs surgery + chemotherapy
 (i) cyclophosphamide* 200/75†
 (ii) busulphan 4*/1.5
Outcomes survival
Notes daily treatment 2 years
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Low risk A ‐ Adequate